3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
8
Terminated
5
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
4
Vomiting
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Prostatic Neoplasms
1
Postoperative Nausea and Vomiting
1
Pain, Intractable
1
Oropharyngeal Neoplasms
1
Nausea
1
Lymphoma, Non-Hodgkin
1
Leukemia, Plasma Cell
1
Immunoglobulin Light-chain Amyloidosis
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Cancer Pain
1
Breast Neoplasms
1
Interventions
Dexamethasone
6
Aprepitant
5
Olanzapine
4
Palonosetron
3
Granisetron
2
yangzheng xiaoji
1
stinging nettle lectin
1
ramosetron
1
peppermint oil
1
niraparib
1
netupitant, palosentron drug combination
1
netupitant
1
lerisetron
1
fosaprepitant
1
Whole Body Imaging
1
Tropisetron
1
Transcranial Direct Current Stimulation
1
Tablets
1
Radiotherapy
1
Paclitaxel
1
Ondansetron
1
Music Therapy
1
Metoclopramide
1
Carboplatin
1
Calcium Dobesilate
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Nausea
×
Calcium Dobesilate
×
Clear all
NCT01913990
2017-01-30
ER11-02
Ottawa Hospital Research Institute
Phase 4
Unknown
323 enrolled